Hospital M&A Holds Its Ground as Larger Systems Push for Scale
Third-quarter hospital and health system mergers kept a steady pace, with 16 announced transactions totaling $8.2 billion in transacted revenue. The volume matched the same quarter in 2025, but the structure of the market tells a more important story: the deal mix is tilting toward larger organizations with enough financial strength to act early, negotiate from a position of leverage, and lock in strategic partners before weaker options disappear.
The latest quarterly review from Vizient, a healthcare performance improvement company based in Irving, Texas, points to a sector still moving through a cycle of consolidation rather than pausing between waves. A particular concern for health system leaders is not simply how many deals are being announced, but who is doing the buying, who is selling, and how large the organizations have become on both sides of the table. When even the smaller participant in a transaction can exceed $1 billion in annual revenue, the industry is no longer dealing only with distressed divestitures or small regional tuck-ins.
The market is consolidating around systems that can absorb risk, spread fixed costs, and extend service lines across broader geographies.
Mega-Mergers Are Reshaping the Deal Mix
Vizient’s analysis suggests 2026 could become a record year for mega-mergers and may also finish as one of the strongest years for total annual transactions since the pandemic began. That does not mean every deal is being driven by financial distress. Many of the newest combinations appear to be planned alliances among organizations seeking growth, technical depth, and geographic expansion before payer pressure, labor costs, and regulatory demands narrow their room to maneuver.
The report described the current environment as one in which larger strategic partnerships are being pursued by organizations operating from stability and strength. Mid-sized hospitals and health systems are also transacting proactively, choosing to reposition before their set of viable options shrinks further. In practical terms, this creates a market where consolidation is not only a defensive act. It is also becoming a way to secure market share, build specialty capabilities, and create a broader referral footprint.
Average annual revenue for the smaller party in these transactions came in at $586 million. Even so, several of the largest announced combinations crossed the mega-merger threshold, and a few others came close. Those numbers matter because they show a sector in which the scale of the participants is rising at the same time the strategic stakes are increasing. The larger the systems become, the more each transaction can change local competition, employment patterns, service distribution, and patient access.
Rush and Endeavor Put the Trend Into Sharp Relief
The clearest example landed just one day after the report’s release: Rush University System for Health and Endeavor Health announced plans to merge in early 2027, pending regulatory review and approval. The combined nonprofit system would bring together 12 hospitals, more than 400 care sites, and 46,000 employees across northern Illinois and northwest Indiana. If completed, the transaction would create one of the largest health systems in Illinois.
Rush, based in Chicago, is a nonprofit academic health system. Endeavor Health, headquartered in Evanston, Illinois, is an integrated health system serving communities across northeastern Illinois. Under the proposal, the combined organization would operate under the Rush name. Endeavor president and CEO J.P. Gallagher would lead the merged system, while Rush president and CEO Omar Lateef would become CEO emeritus and strategic advisor.
The clinical and operational logic is straightforward. Academic medical centers bring research depth, specialty expertise, and tertiary-care capacity. Community-based systems bring local reach, care continuity, and a broader ambulatory network. Combining those strengths can improve referral pathways and widen access to advanced services, but it also concentrates market power and raises questions about pricing, competition, and the practical effects on employers and payers.
A $1 billion investment funded by Endeavor is part of the announced plan, with much of that money intended to support health initiatives tied to the social determinants of health. In a merger of this size, those investments are not window dressing; they are part of the public case for why a larger footprint can translate into better downstream outcomes. Housing, food access, transportation barriers, and neighborhood-level health gaps all affect utilization, chronic disease control, and preventable admissions. A system that can deploy capital at that scale may have more room to address those drivers, though whether those dollars produce measurable community benefit will depend on how they are spent and tracked.
Expansion, Referral Gravity, and Community Reach
The report also used Intermountain Health as an example of how partnerships are being used to extend reach and build service capacity. The Utah-based organization recently acquired two facilities in Idaho from Surgery Partners and also entered a separate joint venture with AdventHealth in Denver. Those kinds of moves show how regional systems are increasingly using a combination of acquisition and joint venture structures to expand into adjacent markets without relying on a single transaction model.
The pattern is consistent across the sector. Health systems are seeking access to new markets, stronger specialty networks, and a more resilient operating base. In many cases, the immediate aim is not just size for its own sake. It is the ability to create a more durable clinical enterprise in a setting where reimbursement pressure, workforce shortages, and regulatory scrutiny continue to intensify.
For patients, the impact can cut in different directions. Larger systems may be able to support more coordinated care, broaden specialty access, and invest in infrastructure that smaller hospitals struggle to afford. At the same time, consolidation can reduce competition, alter local referral patterns, and shift negotiating power in ways that may affect premiums and service availability. Employers and payers in Chicago and beyond will be watching closely, because each new merger becomes a real-world test of whether scale lowers friction or simply redistributes it.
A Market Moving Before the Window Narrows
Vizient’s quarterly framing suggests many organizations are acting before their options narrow. In a period marked by financial headwinds and regulatory uncertainty, timing can determine whether a system shapes its future or accepts terms set by others. The active middle tier of hospitals and health systems appears especially likely to transact while it still has enough strength to choose a partner and negotiate strategic terms rather than waiting until pressures force a more constrained sale.
The third quarter numbers therefore describe more than steady deal flow. They point to an industry where consolidation has become an organizing principle for growth, stability, and market positioning. The unanswered question is not whether health system M&A will continue. The harder issue is how many of these deals will preserve local access, how many will intensify market concentration, and how quickly regulators will scrutinize the larger combinations now entering the pipeline.